Paul A. Meyers
- Pulmonary and Respiratory Medicine top 0.05%
- Molecular Biology top 1%
- Oncology top 0.5%
- Rheumatology top 0.1%
- Surgery top 1%
- Co-authors
- John H. HealeyRichard GörlickAndrew G. HuvosMichael P. LaQuagliaHeribert JuergensIan LewisGlenn HellerLeonard H. Wexler
- Topics
- Sarcoma Diagnosis and Treatment (152 papers)Bone Tumor Diagnosis and Treatments (36 papers)Neuroblastoma Research and Treatments (35 papers)
- Partner nations
- United StatesCanadaUnited Kingdom
In The Last Decade
Paul A. Meyers
258 papers receiving 15.3k citations
Hit Papers
Peers
Comparison fields: 5 of 156
- Pulmonary and Respiratory Medicine 9.0k
- Molecular Biology 4.2k
- Oncology 4.2k
- Rheumatology 3.3k
- Surgery 2.3k
Countries citing papers authored by Paul A. Meyers
This map shows the geographic impact of Paul A. Meyers's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Paul A. Meyers with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Paul A. Meyers more than expected).
Fields of papers citing papers by Paul A. Meyers
This network shows the impact of papers produced by Paul A. Meyers. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Paul A. Meyers. The network helps show where Paul A. Meyers may publish in the future.
Co-authorship network of co-authors of Paul A. Meyers
This figure shows the co-authorship network connecting the top 25 collaborators of Paul A. Meyers. A scholar is included among the top collaborators of Paul A. Meyers based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Paul A. Meyers. Paul A. Meyers is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 13 | |
| 2 | 2 | |
| 3 | 6 | |
| 4 | 15 | |
| 5 | 98 | |
| 6 | 2 | |
| 7 | 184 | |
| 8 | 53 | |
| 9 | 252 | |
| 10 | 23 | |
| 11 | 166 | |
| 12 | Osteosarcoma: The Addition of Muramyl Tripeptide to Chemotherapy Improves Overall Survival—A Report From the Children's Oncology Groupbreakdown → | 520 |
| 13 | 39 | |
| 14 | 54 | |
| 15 | 17 | |
| 16 | The MTOR inhibitor, rapamycin, inhibits growth of Ewing’s sarcoma in vitro and in vivo | 1 |
| 17 | 233 | |
| 18 | 376 | |
| 19 | 227 | |
| 20 | 15 |
About Paul A. Meyers
Paul A. Meyers is a scholar working on Pulmonary and Respiratory Medicine, Rheumatology and Oncology, having authored 262 papers that have together received 15.7k indexed citations. Recurring topics across this work include Sarcoma Diagnosis and Treatment (152 papers), Bone Tumor Diagnosis and Treatments (36 papers) and Neuroblastoma Research and Treatments (35 papers). The work is most often cited by research in Pulmonary and Respiratory Medicine (9.0k citations), Rheumatology (3.3k citations) and Oncology (4.2k citations). Paul A. Meyers has collaborated with scholars based in United States, Canada and United Kingdom. Frequent co-authors include John H. Healey, Richard Görlick, Andrew G. Huvos, Michael P. LaQuaglia, Heribert Juergens, Ian Lewis, Glenn Heller, Leonard H. Wexler, Mark Krailo and Holcombe E. Grier. Their work appears in journals such as New England Journal of Medicine, The Lancet and The Journal of Experimental Medicine.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.